ABVC BioPharma, Inc. (NASDAQ: ABVC) reported Q3 EPS of ($0.02), $0.38 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $380 thousand versus the consensus estimate of $300 thousand.

For earnings history and earnings-related data on ABVC BioPharma, Inc. (ABVC) click here.